The Palico Private Equity Fund Marketplace
Column Group is a private equity general partner firm headquartered in San Francisco, CA, United States.
Biopharmaceutical company Surrozen has closed a $33m Series A round from The Column Group.
Revolution Medicines, which discovers and develops new drugs, has raised $25m in Series A extension from Column Group and others.
Arcus Biosciences, a CA-based immuno-oncology company, raised an additional $70m in Series B equity funding from GV, Invus and others.
Read more news concerning Column Group
A sampling of Column Group portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?